Adynxx, Inc. (OTCPK: ADYX)
Health Care · Biotechnology · US
$—
— today · — 1Y
Adynxx, Inc. (OTCPK: ADYX) operates in the Biotechnology industry within the Health Care sector. The company is valued at $581.00 and employs 6 people.
trading between 0.00 and 0.04.
Tweenvest scores Adynxx, Inc. across four factors: quality 16/100. Its strongest factor is quality.
ADYX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $581.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.82
- Dividend yield
- —
- Beta (5Y)
- -44.59
- 52-week high
- $0.04
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.81M
- Employees
- 6
- Next earnings
- —
About Adynxx, Inc.
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California.
- ISIN
- US00784D1037
- Founded
- 2007
- Listed since
- Dec 18, 1998
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Proteonomix, Inc.OTCPK: PROT | $791.00 | $— | — |
| Pathfinder Cell Therapy, Inc.OTCPK: PFND | $667.00 | $— | — |
| Amarantus BioScience Holdings, Inc.OTCPK: AMBS | $630.00 | $0.00 | — |
| Rosetta Genomics Ltd.OTCPK: ROSG.Q | $593.00 | $— | — |
| GlobeImmune, Inc.OTCPK: GBIM | $575.00 | $0.00 | — |
| Manhattan Scientifics, Inc.OTCPK: MHTX | $559.00 | $0.00 | -99.00% |
| Mera Pharmaceuticals, Inc.OTCPK: MRPI | $537.00 | $— | — |
| Biocept, Inc.OTCPK: BIOC.Q | $525.00 | $0.00 | +100.00% |
Figures last refreshed Oct 4, 2026.